Letrozole
CVD
The University of Texas Health Science Center at San AntonioSmall moleculePhase 3Active
BB
68/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 54/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the CVD cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fenofibrate Baylor College of Medicine | Phase 4 | BB |
Same molecule, other indications
Letrozole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →